Case report : Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature
Hemolytic uremic syndrome (HUS) is a rare thrombotic com-plication characterized by a triad of microangiopathic he-molytic anemia, thrombocytopenia, and acute renal failure. HUS may be caused by several different conditions, including infection, malignancy, and chemotherapeutic agents, such as mitom...
Gespeichert in:
| Veröffentlicht in: | Gut and liver 2014-01, Vol.8 (1), p.109 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | 109 |
| container_title | Gut and liver |
| container_volume | 8 |
| creator | Hye Won Lee Moon Jae Chung Huap Yong Kang Heun Choi Youn Jeong Choi Kyung Joo Lee Seung Woo Lee Seung Hyuk Han Jin Seok Kim Si Young Song |
| description | Hemolytic uremic syndrome (HUS) is a rare thrombotic com-plication characterized by a triad of microangiopathic he-molytic anemia, thrombocytopenia, and acute renal failure. HUS may be caused by several different conditions, including infection, malignancy, and chemotherapeutic agents, such as mitomycin, cisplatin, and most recently, gemcitabine. The outcome of gemcitabine-induced HUS is poor, and the dis-ease has a high mortality rate. This study reports a case of gemcitabine-induced HUS in a patient with pancreatic cancer in Korea. (Gut Liver 2014;8:109-112) |
| format | Article |
| fullrecord | <record><control><sourceid>kiss</sourceid><recordid>TN_cdi_kiss_primary_3198762</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><kiss_id>3198762</kiss_id><sourcerecordid>3198762</sourcerecordid><originalsourceid>FETCH-kiss_primary_31987623</originalsourceid><addsrcrecordid>eNp9jMkKwjAUAHNQsC5f4OX9QKELttWbFDfwIC7nEtMnRk1aXlKl4Mdbl7OnGRiYFnP8cRy5QZCEHdY15uJ5kR_EI4c9U24QCMuCLExggUpIy49So7vSeSUwhyWq4lZbKeBAqBrsap1ToRCkhg3XgpC_a9oo0gSm8Hluv0-u80bvEh9QnMCeEdbSInFbEfZZ-8RvBgc_9thwPtunS_cqjclKkopTnYX-OImjIPxfX5H9R6k</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Case report : Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature</title><source>DOAJ Directory of Open Access Journals</source><source>KoreaMed Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Hye Won Lee ; Moon Jae Chung ; Huap Yong Kang ; Heun Choi ; Youn Jeong Choi ; Kyung Joo Lee ; Seung Woo Lee ; Seung Hyuk Han ; Jin Seok Kim ; Si Young Song</creator><creatorcontrib>Hye Won Lee ; Moon Jae Chung ; Huap Yong Kang ; Heun Choi ; Youn Jeong Choi ; Kyung Joo Lee ; Seung Woo Lee ; Seung Hyuk Han ; Jin Seok Kim ; Si Young Song</creatorcontrib><description>Hemolytic uremic syndrome (HUS) is a rare thrombotic com-plication characterized by a triad of microangiopathic he-molytic anemia, thrombocytopenia, and acute renal failure. HUS may be caused by several different conditions, including infection, malignancy, and chemotherapeutic agents, such as mitomycin, cisplatin, and most recently, gemcitabine. The outcome of gemcitabine-induced HUS is poor, and the dis-ease has a high mortality rate. This study reports a case of gemcitabine-induced HUS in a patient with pancreatic cancer in Korea. (Gut Liver 2014;8:109-112)</description><identifier>ISSN: 1976-2283</identifier><language>kor</language><publisher>대한소화기학회</publisher><subject>Gemcitabine ; Hemolytic-uremic syndrome ; Pancreatic neoplasms</subject><ispartof>Gut and liver, 2014-01, Vol.8 (1), p.109</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Hye Won Lee</creatorcontrib><creatorcontrib>Moon Jae Chung</creatorcontrib><creatorcontrib>Huap Yong Kang</creatorcontrib><creatorcontrib>Heun Choi</creatorcontrib><creatorcontrib>Youn Jeong Choi</creatorcontrib><creatorcontrib>Kyung Joo Lee</creatorcontrib><creatorcontrib>Seung Woo Lee</creatorcontrib><creatorcontrib>Seung Hyuk Han</creatorcontrib><creatorcontrib>Jin Seok Kim</creatorcontrib><creatorcontrib>Si Young Song</creatorcontrib><title>Case report : Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature</title><title>Gut and liver</title><addtitle>Gut and Liver</addtitle><description>Hemolytic uremic syndrome (HUS) is a rare thrombotic com-plication characterized by a triad of microangiopathic he-molytic anemia, thrombocytopenia, and acute renal failure. HUS may be caused by several different conditions, including infection, malignancy, and chemotherapeutic agents, such as mitomycin, cisplatin, and most recently, gemcitabine. The outcome of gemcitabine-induced HUS is poor, and the dis-ease has a high mortality rate. This study reports a case of gemcitabine-induced HUS in a patient with pancreatic cancer in Korea. (Gut Liver 2014;8:109-112)</description><subject>Gemcitabine</subject><subject>Hemolytic-uremic syndrome</subject><subject>Pancreatic neoplasms</subject><issn>1976-2283</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9jMkKwjAUAHNQsC5f4OX9QKELttWbFDfwIC7nEtMnRk1aXlKl4Mdbl7OnGRiYFnP8cRy5QZCEHdY15uJ5kR_EI4c9U24QCMuCLExggUpIy49So7vSeSUwhyWq4lZbKeBAqBrsap1ToRCkhg3XgpC_a9oo0gSm8Hluv0-u80bvEh9QnMCeEdbSInFbEfZZ-8RvBgc_9thwPtunS_cqjclKkopTnYX-OImjIPxfX5H9R6k</recordid><startdate>20140130</startdate><enddate>20140130</enddate><creator>Hye Won Lee</creator><creator>Moon Jae Chung</creator><creator>Huap Yong Kang</creator><creator>Heun Choi</creator><creator>Youn Jeong Choi</creator><creator>Kyung Joo Lee</creator><creator>Seung Woo Lee</creator><creator>Seung Hyuk Han</creator><creator>Jin Seok Kim</creator><creator>Si Young Song</creator><general>대한소화기학회</general><scope>HZB</scope><scope>Q5X</scope></search><sort><creationdate>20140130</creationdate><title>Case report : Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature</title><author>Hye Won Lee ; Moon Jae Chung ; Huap Yong Kang ; Heun Choi ; Youn Jeong Choi ; Kyung Joo Lee ; Seung Woo Lee ; Seung Hyuk Han ; Jin Seok Kim ; Si Young Song</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kiss_primary_31987623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2014</creationdate><topic>Gemcitabine</topic><topic>Hemolytic-uremic syndrome</topic><topic>Pancreatic neoplasms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hye Won Lee</creatorcontrib><creatorcontrib>Moon Jae Chung</creatorcontrib><creatorcontrib>Huap Yong Kang</creatorcontrib><creatorcontrib>Heun Choi</creatorcontrib><creatorcontrib>Youn Jeong Choi</creatorcontrib><creatorcontrib>Kyung Joo Lee</creatorcontrib><creatorcontrib>Seung Woo Lee</creatorcontrib><creatorcontrib>Seung Hyuk Han</creatorcontrib><creatorcontrib>Jin Seok Kim</creatorcontrib><creatorcontrib>Si Young Song</creatorcontrib><collection>Korean Studies Information Service System (KISS)</collection><collection>Korean Studies Information Service System (KISS) B-Type</collection><jtitle>Gut and liver</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hye Won Lee</au><au>Moon Jae Chung</au><au>Huap Yong Kang</au><au>Heun Choi</au><au>Youn Jeong Choi</au><au>Kyung Joo Lee</au><au>Seung Woo Lee</au><au>Seung Hyuk Han</au><au>Jin Seok Kim</au><au>Si Young Song</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case report : Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature</atitle><jtitle>Gut and liver</jtitle><addtitle>Gut and Liver</addtitle><date>2014-01-30</date><risdate>2014</risdate><volume>8</volume><issue>1</issue><spage>109</spage><pages>109-</pages><issn>1976-2283</issn><abstract>Hemolytic uremic syndrome (HUS) is a rare thrombotic com-plication characterized by a triad of microangiopathic he-molytic anemia, thrombocytopenia, and acute renal failure. HUS may be caused by several different conditions, including infection, malignancy, and chemotherapeutic agents, such as mitomycin, cisplatin, and most recently, gemcitabine. The outcome of gemcitabine-induced HUS is poor, and the dis-ease has a high mortality rate. This study reports a case of gemcitabine-induced HUS in a patient with pancreatic cancer in Korea. (Gut Liver 2014;8:109-112)</abstract><pub>대한소화기학회</pub><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1976-2283 |
| ispartof | Gut and liver, 2014-01, Vol.8 (1), p.109 |
| issn | 1976-2283 |
| language | kor |
| recordid | cdi_kiss_primary_3198762 |
| source | DOAJ Directory of Open Access Journals; KoreaMed Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Gemcitabine Hemolytic-uremic syndrome Pancreatic neoplasms |
| title | Case report : Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T16%3A11%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kiss&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20report%20:%20Gemcitabine-Induced%20Hemolytic%20Uremic%20Syndrome%20in%20Pancreatic%20Cancer:%20A%20Case%20Report%20and%20Review%20of%20the%20Literature&rft.jtitle=Gut%20and%20liver&rft.au=Hye%20Won%20Lee&rft.date=2014-01-30&rft.volume=8&rft.issue=1&rft.spage=109&rft.pages=109-&rft.issn=1976-2283&rft_id=info:doi/&rft_dat=%3Ckiss%3E3198762%3C/kiss%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_kiss_id=3198762&rfr_iscdi=true |